| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5699681 | Clinical Oncology | 2008 | 8 Pages |
Abstract
CPT-11 plus capecitabine with a 14 day cycle showed a comparable response with international phase II data with a 3 weekly regimen and was well tolerated as a first-line palliative chemotherapy in patients with metastatic colorectal cancer. The data should be interpreted with caution due to the limited sample size and should be further confirmed by a phase III randomised trial.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
C.K.K. Choi, R.T.T. Chan, S.Y. Tung, L. Lui, S. Siu, G.K.H. Au, J.W.C. Ho, W.L. Law,